Boris Quednow
Professor of Psychiatry and Psychopharmacology
Papers
Trials
Key Impact
A leading translational researcher known for experimental studies on MDMA, methamphetamine and serotonergic compounds that link neurochemical and neurophysiological measures to social‑cognitive and behavioural outcomes.
Background & Research
Boris B. Quednow is a clinician‑scientist whose work sits at the intersection of psychopharmacology, neuropsychiatry and experimental medicine. He has led and contributed to controlled human studies examining the behavioural and neurochemical effects of recreational and therapeutic psychoactive compounds, including comparative investigations of MDMA and methamphetamine, magnetic resonance spectroscopy studies of glutamate and GABA in relation to chronic MDMA use, neurophysiological assessments of conflict monitoring and emotional processing, and factorial dose‑escalation work probing the pharmacokinetic and pharmacodynamic interaction between N,N‑dimethyltryptamine (DMT) and the monoamine oxidase inhibitor harmine in healthy volunteers.